Literature DB >> 33865202

Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.

Abedul Haque1, Daniel Brazeau2, Arm R Amin3.   

Abstract

Cancer is the second deadliest disease worldwide. Although recent advances applying precision treatments with targeted (molecular and immune) agents are promising, the histological and molecular heterogeneity of cancer cells and huge mutational burdens (intrinsic or acquired after therapy) leading to drug resistance and treatment failure are posing continuous challenges. These recent advances do not negate the need for alternative approaches such as chemoprevention, the pharmacological approach to reverse, suppress or prevent the initial phases of carcinogenesis or the progression of premalignant cells to invasive disease by using non-toxic agents. Although data are limited, the success of several clinical trials in preventing cancer in high-risk populations suggests that chemoprevention is a rational, appealing and viable strategy to prevent carcinogenesis. Particularly among higher-risk groups, the use of safe, non-toxic agents is the utmost consideration because these individuals have not yet developed invasive disease. Natural dietary compounds present in fruits, vegetables and spices are especially attractive for chemoprevention and treatment because of their easy availability, high margin of safety, relatively low cost and widespread human consumption. Hundreds of such compounds have been widely investigated for chemoprevention and treatment in the last few decades. Previously, we reviewed the most widely studied natural compounds and their molecular mechanisms, which were highly exploited by the cancer research community. In the time since our initial review, many promising new compounds have been identified. In this review, we critically review these promising new natural compounds, their molecular targets and mechanisms of anticancer activity that may create novel opportunities for further design and conduct of preclinical and clinical studies.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Chemoprevention; Molecular targets; Natural compounds

Mesh:

Substances:

Year:  2021        PMID: 33865202      PMCID: PMC8113151          DOI: 10.1016/j.ejca.2021.03.009

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  204 in total

1.  Inhibitory effect of ursolic acid and oleanolic acid from Eriobotrya fragrans on A549 cell viability in vivo.

Authors:  Y S Gao; Y Yuan; G Song; S Q Lin
Journal:  Genet Mol Res       Date:  2016-05-13

2.  Characterization of 3alpha-acetyl-11-keto-alpha-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivo.

Authors:  Berthold Büchele; Waltraud Zugmaier; Aidee Estrada; Felicitas Genze; Tatiana Syrovets; Christian Paetz; Bernd Schneider; Thomas Simmet
Journal:  Planta Med       Date:  2006-10-04       Impact factor: 3.352

3.  Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.

Authors:  Radha Munagala; Hina Kausar; Charu Munjal; Ramesh C Gupta
Journal:  Carcinogenesis       Date:  2011-08-22       Impact factor: 4.944

4.  Efficacy of deguelin and silibinin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice.

Authors:  Ying Yan; Yian Wang; Qing Tan; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

5.  Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization.

Authors:  Steven J T Jackson; Keith W Singletary
Journal:  Carcinogenesis       Date:  2003-10-24       Impact factor: 4.944

6.  PARP cleavage and perturbance in mitochondrial membrane potential by 3-α-propionyloxy-β-boswellic acid results in cancer cell death and tumor regression in murine models.

Authors:  Yasrib Qurishi; Abid Hamid; Parduman R Sharma; Zahoor Ahmad Wani; Dilip M Mondhe; Shashank K Singh; Mohmmad Afzal Zargar; Samar S Andotra; Bhahwal Ali Shah; Subhash C Taneja; Ajit Kumar Saxena
Journal:  Future Oncol       Date:  2012-07       Impact factor: 3.404

7.  Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex.

Authors:  M Kobori; Z Yang; D Gong; V Heissmeyer; H Zhu; Y-K Jung; M Angelica M Gakidis; A Rao; T Sekine; F Ikegami; C Yuan; J Yuan
Journal:  Cell Death Differ       Date:  2004-01       Impact factor: 15.828

8.  Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells.

Authors:  Ganchimeg Ishdorj; James B Johnston; Spencer B Gibson
Journal:  BMC Cancer       Date:  2011-06-24       Impact factor: 4.430

9.  Cucurbitacin B induced ATM-mediated DNA damage causes G2/M cell cycle arrest in a ROS-dependent manner.

Authors:  Jiajie Guo; Guosheng Wu; Jiaolin Bao; Wenhui Hao; Jinjian Lu; Xiuping Chen
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

10.  Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.

Authors:  Jiang-Jiang Qin; Wei Wang; Sukesh Voruganti; Hui Wang; Wei-Dong Zhang; Ruiwen Zhang
Journal:  Oncotarget       Date:  2015-02-20
View more
  6 in total

Review 1.  Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms.

Authors:  Essa M Bajalia; Farah B Azzouz; Danielle A Chism; Derrek M Giansiracusa; Carina G Wong; Kristina N Plaskett; Anupam Bishayee
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

2.  Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer.

Authors:  Keisuke Okuno; Rachana Garg; Yate-Ching Yuan; Masanori Tokunaga; Yusuke Kinugasa; Ajay Goel
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

3.  Cdc25C/cdc2/cyclin B, raf/MEK/ERK and PERK/eIF2α/CHOP pathways are involved in forskolin-induced growth inhibition of MM.1S cells by G2/M arrest and mitochondrion-dependent apoptosis.

Authors:  Ping Yang; Pei-Wen Jiang; Chen Li; Ming-Xiang Gao; Yi-Song Sun; Dan-Ying Zhang; Wen-Qian Du; Jing Zhao; Song-Ting Shi; Yan Li; Tai Yang; Li Cheng; Min-Hui Li
Journal:  Cell Cycle       Date:  2021-10-04       Impact factor: 5.173

4.  Anticancer Properties of Plectranthus ornatus-Derived Phytochemicals Inducing Apoptosis via Mitochondrial Pathway.

Authors:  Przemysław Sitarek; Ewelina Synowiec; Tomasz Kowalczyk; Gabrielle Bangay; Tomasz Śliwiński; Laurent Picot; Salvatore Princiotto; Patricia Rijo
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

Review 5.  Modulation of Nrf2 and NF-κB Signaling Pathways by Naturally Occurring Compounds in Relation to Cancer Prevention and Therapy. Are Combinations Better Than Single Compounds?

Authors:  Violetta Krajka-Kuźniak; Wanda Baer-Dubowska
Journal:  Int J Mol Sci       Date:  2021-07-30       Impact factor: 6.208

6.  Multiple Effects of Resveratrol on Osteosarcoma Cell Lines.

Authors:  Angela De Luca; Daniele Bellavia; Lavinia Raimondi; Valeria Carina; Viviana Costa; Milena Fini; Gianluca Giavaresi
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.